These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7338883)

  • 1. Defective activation of the alternative pathway of complement in two brothers with ataxia-telangiectasia.
    Saint-Remy JM; Dent RG; Cole P
    J Clin Lab Immunol; 1981 Nov; 6(3):221-6. PubMed ID: 7338883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective defects in T cell function in ataxia-telangiectasia.
    Levis WR; Dattner AM; Shaw JS
    Clin Exp Immunol; 1979 Jul; 37(1):44-9. PubMed ID: 158450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-year follow-up of 160 patients with ataxia-telangiectasia.
    Ersoy F; Berkel AI; Sanal O; Oktay H
    Turk J Pediatr; 1991; 33(4):205-15. PubMed ID: 1814037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic and cytogenetic aspects of ataxia telangiectasia].
    Weemaes CM; Taalman RD; Van Munster PJ; Hustinx TW; Bakkeren JA; Scheres JM
    Tijdschr Kindergeneeskd; 1984 Aug; 52(4):164-9. PubMed ID: 6333737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of the immunological deficiency in ataxia-telangiectasia: absence of a clinical-pathological correlation.
    Roifman CM; Gelfand EW
    Kroc Found Ser; 1985; 19():273-85. PubMed ID: 3877786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency and infections in ataxia-telangiectasia.
    Nowak-Wegrzyn A; Crawford TO; Winkelstein JA; Carson KA; Lederman HM
    J Pediatr; 2004 Apr; 144(4):505-11. PubMed ID: 15069401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia.
    Sanal O; Ozbaş-Gerçeker F; Yel L; Ersoy F; Tezcan I; Berkel AI; Metin A; Gatti RA
    Turk J Pediatr; 2004; 46(3):208-13. PubMed ID: 15503472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal OKT4/OKT8 ratio and deranged capping in ataxia-telangiectasia.
    Barbieri MC; Bertanza C; Ferrero E; Colombo G; Baldini V; Besana C
    Boll Ist Sieroter Milan; 1985; 64(3):232-5. PubMed ID: 3840025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
    Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
    Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia-telangiectasia: a clinical and laboratory review study of 14 cases.
    Schwartzman JS; Solé D; Naspitz CK
    Allergol Immunopathol (Madr); 1990; 18(2):105-11. PubMed ID: 1695474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
    Weinstein S; Scottolini AG; Loo SY; Caldwell PC; Bhagavan NV
    Arch Pathol Lab Med; 1985 Nov; 109(11):1000-4. PubMed ID: 2996458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ataxia telangiectasia: 3 clinical cases with immunological study and autopsy report].
    Grossi-Bianchi ML; Moscatelli P; Tassara A
    Minerva Pediatr; 1971 Aug; 23(33):1350-8. PubMed ID: 5122472
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunological deficiency state in ataxia-telangiectasia.
    McFarlin DE; Strober W; Barlow M; Waldmann T
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():275-92. PubMed ID: 4943905
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cell mediated cytotoxic activities in ataxia-telangiectasia with T cell deficiency].
    Tsuge I; Matsuoka H; Okada J; Mizuno T; Matsuoka M; Torii S; Kodera Y; Takahashi T
    Arerugi; 1984 Oct; 33(10):909-16. PubMed ID: 6335392
    [No Abstract]   [Full Text] [Related]  

  • 17. Ataxia-telangiectasia. X,14 translocation, progressive deterioration of lymphocyte numbers and function, and abnormal in vitro immunoglobulin production.
    Beatty DW; Arens LJ; Nelson MM
    S Afr Med J; 1986 Jan; 69(2):115-8. PubMed ID: 2417340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoblastic transformation, chromosome picture and delayed skin reaction in ataxia teleangiectasia].
    Schuler D; Schöngut L; Cserháti E; Siegler J; Gács G
    Orv Hetil; 1969 Sep; 110(39):2279-82. PubMed ID: 4187094
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer factor therapy in ataxia--telangiectasia.
    Berkel AI; Ersoy F; Epstein LB; Spitler LE
    Clin Exp Immunol; 1977 Sep; 29(3):376-84. PubMed ID: 201409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.